Payment overview · 2025
General Payments
$43.25
1 reported records · 1 companies
Healthcare provider profile · identity verified
Terri Lynn Eckert, M.D.
Allopathic & Osteopathic Physicians|Family Medicine|Geriatric Medicine · ATHENS, TX · NPI 1124024765
Verified facts
What the public records show
CMS Open Payments records show Terri Lynn Eckert, M.D. received $43.25 in general payments during 2025 across 1 reported records.
AstraZeneca Pharmaceuticals LP accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 21 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 21 claims for Symbicort by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $43.25 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $43.25 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ENHERTU Normalized: enhertu |
Biological | AstraZeneca Pharmaceuticals LP | $43.25 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
21 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
21 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 820 | 239 |
| Levothyroxine Sodium | Levothyroxine Sodium | 721 | 189 |
| Lisinopril | Lisinopril | 589 | 166 |
| Gabapentin | Gabapentin | 509 | 135 |
| Famotidine | Famotidine | 426 | 143 |
| Losartan Potassium | Losartan Potassium | 419 | 111 |
| Hydrochlorothiazide | Hydrochlorothiazide | 399 | 105 |
| Trazodone Hcl | Trazodone Hcl | 361 | 103 |
| Amlodipine Besylate | Amlodipine Besylate | 325 | 107 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 320 | 91 |
| Furosemide | Furosemide | 317 | 84 |
| Metformin Hcl | Metformin Hcl | 303 | 90 |
| Metoprolol Succinate | Metoprolol Succinate | 300 | 89 |
| Omeprazole | Omeprazole | 289 | 82 |
| Tramadol Hcl | Tramadol Hcl | 286 | 60 |
| Ezetimibe | Ezetimibe | 281 | 82 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 275 | 56 |
| Montelukast Sodium | Montelukast Sodium | 266 | 86 |
| Escitalopram Oxalate | Escitalopram Oxalate | 256 | 69 |
| Potassium Chloride | Potassium Chloride | 255 | 77 |
| Pantoprazole Sodium | Pantoprazole Sodium | 253 | 75 |
| Simvastatin | Simvastatin | 249 | 66 |
| Fluticasone Propionate | Fluticasone Propionate | 239 | 76 |
| Carvedilol | Carvedilol | 233 | 69 |
| Memantine Hcl | Memantine Hcl | 223 | 50 |
| Alendronate Sodium | Alendronate Sodium | 206 | 53 |
| Sertraline Hcl | Sertraline Hcl | 191 | 48 |
| Tamsulosin Hcl | Tamsulosin Hcl | 188 | 56 |
| Duloxetine Hcl | Duloxetine Hcl | 173 | 40 |
| Buspirone Hcl | Buspirone Hcl | 170 | 49 |
| Meloxicam | Meloxicam | 168 | 40 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 164 | 57 |
| Glimepiride | Glimepiride | 153 | 53 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 147 | 34 |
| Metoprolol Tartrate | Metoprolol Tartrate | 146 | 51 |
| Eliquis | Apixaban | 141 | 38 |
| Clopidogrel | Clopidogrel Bisulfate | 138 | 43 |
| Allopurinol | Allopurinol | 135 | 36 |
| Bupropion Xl | Bupropion Hcl | 133 | 40 |
| Fluoxetine Hcl | Fluoxetine Hcl | 130 | 40 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 126 | 30 |
| Ozempic | Semaglutide | 104 | 20 |
| Donepezil Hcl | Donepezil Hcl | 99 | 27 |
| Azithromycin | Azithromycin | 98 | 63 |
| Tizanidine Hcl | Tizanidine Hcl | 98 | 33 |
| Zolpidem Tartrate | Zolpidem Tartrate | 96 | 16 |
| Cefuroxime | Cefuroxime Axetil | 92 | 76 |
| Pravastatin Sodium | Pravastatin Sodium | 88 | 29 |
| Prednisone | Prednisone | 85 | 33 |
| Estradiol | Estradiol | 83 | 32 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 83 | 25 |
| Bupropion Hcl Sr | Bupropion Hcl | 81 | 24 |
| Mirtazapine | Mirtazapine | 79 | 20 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 76 | 29 |
| Trulicity | Dulaglutide | 75 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 70 | 22 |
| Nifedipine Er | Nifedipine | 70 | 15 |
| Ondansetron Odt | Ondansetron | 70 | 40 |
| Methylprednisolone | Methylprednisolone | 69 | 49 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 67 | 19 |
| Quetiapine Fumarate | Quetiapine Fumarate | 67 | suppressed |
| Alprazolam | Alprazolam | 66 | 16 |
| Methocarbamol | Methocarbamol | 66 | 19 |
| Celecoxib | Celecoxib | 65 | 20 |
| Baclofen | Baclofen | 64 | 17 |
| Ibandronate Sodium | Ibandronate Sodium | 63 | 15 |
| Atenolol | Atenolol | 61 | 22 |
| Synthroid | Levothyroxine Sodium | 60 | 16 |
| Spironolactone | Spironolactone | 58 | 21 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 56 | 21 |
| Clonazepam | Clonazepam | 55 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 55 | 13 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 55 | 18 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 54 | 17 |
| Rybelsus | Semaglutide | 54 | 14 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 53 | 20 |
| Benazepril Hcl | Benazepril Hcl | 52 | 16 |
| Eszopiclone | Eszopiclone | 52 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 51 | 17 |
| Bumetanide | Bumetanide | 51 | 15 |
| Meclizine Hcl | Meclizine Hcl | 51 | 17 |
| Xarelto | Rivaroxaban | 51 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 50 | 45 |
| Jardiance | Empagliflozin | 50 | suppressed |
| Pregabalin | Pregabalin | 50 | 17 |
| Ventolin Hfa | Albuterol Sulfate | 50 | 17 |
| Valacyclovir | Valacyclovir Hcl | 49 | 23 |
| Citalopram Hbr | Citalopram Hydrobromide | 48 | 16 |
| Ropinirole Hcl | Ropinirole Hcl | 48 | 14 |
| Fenofibrate | Fenofibrate Nanocrystallized | 47 | 19 |
| Fluconazole | Fluconazole | 47 | 31 |
| Azelastine Hcl | Azelastine Hcl | 45 | 18 |
| Ketoconazole | Ketoconazole | 45 | 29 |
| Lactulose | Lactulose | 44 | 17 |
| Lorazepam | Lorazepam | 44 | 14 |
| Divalproex Sodium | Divalproex Sodium | 42 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 42 | 13 |
| Mupirocin | Mupirocin | 42 | 23 |
| Mounjaro | Tirzepatide | 40 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 40 | 29 |
| Warfarin Sodium | Warfarin Sodium | 39 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 38 | 13 |
| Irbesartan | Irbesartan | 38 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 37 | suppressed |
| Ramipril | Ramipril | 36 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 35 | 30 |
| Ipratropium Bromide | Ipratropium Bromide | 34 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 34 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 34 | suppressed |
| Lovastatin | Lovastatin | 33 | 11 |
| Testosterone Cypionate | Testosterone Cypionate | 33 | 11 |
| Doxycycline Hyclate | Doxycycline Hyclate | 32 | 30 |
| Paroxetine Hcl | Paroxetine Hcl | 31 | 13 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 30 | suppressed |
| Cephalexin | Cephalexin | 30 | 26 |
| Fenofibrate | Fenofibrate | 30 | suppressed |
| Januvia | Sitagliptin Phosphate | 30 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Temazepam | Temazepam | 30 | suppressed |
| Linzess | Linaclotide | 29 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 29 | suppressed |
| Acyclovir | Acyclovir | 28 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 28 | 14 |
| Lansoprazole | Lansoprazole | 28 | suppressed |
| Torsemide | Torsemide | 28 | suppressed |
| Chlorthalidone | Chlorthalidone | 26 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Nitroglycerin | Nitroglycerin | 26 | 21 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 26 | suppressed |
| Colchicine | Colchicine | 25 | 13 |
| Dicyclomine Hcl | Dicyclomine Hcl | 25 | 12 |
| Doxazosin Mesylate | Doxazosin Mesylate | 25 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 24 | 14 |
| Praluent Pen | Alirocumab | 24 | suppressed |
| Sotalol | Sotalol Hcl | 24 | suppressed |
| Glipizide | Glipizide | 23 | suppressed |
| Nystatin | Nystatin | 23 | suppressed |
| Digoxin | Digoxin | 22 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 22 | suppressed |
| Hydrocortisone | Hydrocortisone | 22 | suppressed |
| Naproxen | Naproxen | 22 | suppressed |
| Progesterone | Progesterone, Micronized | 22 | suppressed |
| Sulfasalazine | Sulfasalazine | 22 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 21 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Latanoprost | Latanoprost | 21 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 21 | suppressed |
| Armour Thyroid | Thyroid,pork | 20 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 20 | suppressed |
| Finasteride | Finasteride | 20 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 20 | suppressed |
| Myrbetriq | Mirabegron | 20 | suppressed |
| Rivastigmine | Rivastigmine | 20 | suppressed |
| Verapamil Er | Verapamil Hcl | 20 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 19 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 19 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 19 | suppressed |
| Gemfibrozil | Gemfibrozil | 19 | suppressed |
| Modafinil | Modafinil | 19 | suppressed |
| Carbamazepine | Carbamazepine | 18 | suppressed |
| Constulose | Lactulose | 18 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 18 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 18 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 18 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 18 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 17 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 17 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 17 | suppressed |
| Dutasteride | Dutasteride | 17 | suppressed |
| Lidocaine | Lidocaine | 17 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 17 | suppressed |
| Sucralfate | Sucralfate | 17 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 17 | 15 |
| Sumatriptan Succinate | Sumatriptan Succinate | 17 | suppressed |
| Entresto | Sacubitril/Valsartan | 16 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 16 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 16 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 16 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 16 | suppressed |
| Methimazole | Methimazole | 15 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 15 | suppressed |
| Repatha Sureclick | Evolocumab | 15 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 15 | suppressed |
| Amoxicillin | Amoxicillin | 14 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 14 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 14 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 14 | suppressed |
| Ibuprofen | Ibuprofen | 14 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 14 | suppressed |
| Valsartan | Valsartan | 14 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 14 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 13 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 13 | suppressed |
| Felodipine Er | Felodipine | 13 | suppressed |
| Levemir Flexpen | Insulin Detemir | 13 | suppressed |
| Levofloxacin | Levofloxacin | 13 | 11 |
| Metronidazole | Metronidazole | 13 | 12 |
| Probenecid | Probenecid | 13 | suppressed |
| Dipyridamole | Dipyridamole | 12 | suppressed |
| Levetiracetam | Levetiracetam | 12 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 12 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 12 | suppressed |
| Methotrexate | Methotrexate Sodium | 11 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 11 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 11 | suppressed |
| Ranolazine Er | Ranolazine | 11 | suppressed |
| Verapamil Er Pm | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $43.25 · 1 records | AstraZeneca Pharmaceuticals LP | ENHERTU | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error